What Does Multiple Myeloma Look Like Scans To Skin?

Multiple myeloma shows up differently on scans and skin, and the two are not directly connected. On imaging like X-rays, CT, PET, or MRI, it appears as punched-out holes in bone or areas of abnormal cell activity. On the skin, it does not cause a specific rash, but some people develop bruising, small red spots, or rare growths called plasmacytomas. The key point is that skin findings are not a reliable way to spot this cancer — scans are the real diagnostic tool.

What Do Bone Lesions From Multiple Myeloma Look Like on Scans?

Bone lesions are the most common sign of multiple myeloma on imaging. On standard X-rays, they appear as round, sharply defined holes in the bone. Radiologists call these “punched-out” lesions because they look like someone took a small cookie cutter to the bone.

These lesions can appear anywhere but are most common in the skull, spine, ribs, pelvis, and long bones of the arms and legs. A skeletal survey — a series of X-rays of the whole body — has been the standard test for decades. The International Myeloma Working Group still recommends it for initial diagnosis.

CT scans show these lesions in more detail. They can reveal smaller holes that X-rays might miss. MRI is even more sensitive for detecting early bone marrow involvement before any hole forms. PET scans add another layer by showing which lesions are actively growing — they light up on the scan because myeloma cells consume more sugar than normal cells.

What Does Multiple Myeloma Look Like on PET Scans Compared to CT or MRI?

PET scans and CT or MRI scans show different things. CT and MRI show structure — the physical holes or masses in bone. PET shows activity — whether cells are metabolically active and likely growing.

A PET scan uses a radioactive tracer called FDG, which is a form of sugar. Cancer cells take up more FDG than normal cells. On the resulting image, active myeloma lesions appear as bright spots. The standard measure is called SUVmax, and values above 2.5 are generally considered suspicious, though this threshold varies by institution.

MRI is better for detecting diffuse marrow involvement — when myeloma cells spread throughout the bone marrow without forming distinct holes. This pattern is common and easily missed on X-ray or CT. Research published in the Journal of Clinical Oncology found that MRI detects marrow abnormalities in about 30% of patients who have normal X-rays.

Can Multiple Myeloma Show Up on the Skin?

Multiple myeloma rarely affects the skin directly. When it does, the most common finding is a plasmacytoma — a collection of myeloma cells that forms a visible lump under the skin. These are firm, flesh-colored or reddish nodules that can appear anywhere on the body.

More often, skin changes are indirect. Low blood counts from myeloma can cause easy bruising, small red or purple dots called petechiae, and pale skin from anemia. These are not specific to myeloma — they happen with many conditions that affect blood cell production.

Some people develop cryoglobulinemia, where abnormal proteins in the blood clump together in cold temperatures and cause purplish skin patches on the fingers, toes, ears, or nose. This is uncommon but well-documented in the medical literature.

There is also a rare skin condition called myeloma-associated systemic amyloidosis. Amyloid proteins deposit in the skin, causing waxy, thickened areas, easy bruising around the eyes (raccoon eyes), and a tendency to bleed. This affects about 10-15% of people with multiple myeloma.

What Do Common Skin Findings Actually Look Like in Multiple Myeloma?

Petechiae appear as tiny red or purple dots, usually on the lower legs. They look like a rash but do not blanch when you press on them. They are caused by low platelet counts — a common complication of myeloma because the cancer crowds out normal bone marrow cells.

Bruising in myeloma patients often happens with minimal injury. Large purplish patches can appear on the arms, legs, or trunk. This is not from the cancer itself but from low platelets or abnormal proteins that interfere with normal clotting.

Pale skin is another indirect sign. It is caused by anemia — low red blood cell counts. The skin may look washed out, especially in the inner lining of the lower eyelids and the nail beds. This is a general sign that warrants a blood test, not a specific sign of myeloma.

Rarely, skin lesions can be the first clue. Case reports describe patients who visited a dermatologist for a lump or rash, and the biopsy revealed myeloma. This is unusual but worth knowing — any persistent, unexplained skin growth should be biopsied, especially in someone over 60.

What Does Research on the Link Between Scans and Skin Findings Show?

Research clearly shows that skin findings are not a substitute for imaging. A 2020 review in Blood Reviews noted that cutaneous involvement occurs in less than 5% of myeloma cases. The vast majority of patients have no skin signs at all.

Studies have found that the severity of bone lesions on scans does not predict skin findings. A person with widespread holes on X-ray may have completely normal skin. Conversely, someone with a visible plasmacytoma may have only minimal bone involvement.

The National Comprehensive Cancer Network guidelines emphasize that imaging is the primary method for detecting bone disease in myeloma. Skin examination is part of a complete physical exam but is not a screening tool. The American Society of Hematology recommends skeletal imaging for anyone suspected of having myeloma, regardless of skin appearance.

Some studies suggest that PET scan findings correlate with overall disease activity better than skin findings do. A high SUVmax on PET is associated with more aggressive disease and worse outcomes. Skin findings do not have this predictive value.

How Do Doctors Use These Findings Together for Diagnosis?

Diagnosis of multiple myeloma requires a combination of tests. Imaging shows bone damage. Blood tests detect abnormal proteins. A bone marrow biopsy confirms the presence of myeloma cells. Skin findings alone are never enough for diagnosis.

If a patient has suspicious skin lesions, the doctor will biopsy them. If the biopsy shows myeloma cells, it confirms that the disease has spread to the skin. This is called extramedullary disease — myeloma outside the bone marrow — and it may require different treatment.

Scans guide treatment decisions. A patient with many bone lesions may need radiation or surgery to prevent fractures. A patient with no lesions on scan but abnormal blood tests may be watched closely without immediate treatment. This is called smoldering myeloma.

Monitoring involves repeat scans. After treatment, PET scans can show whether lesions have become less active. MRI can show whether bone marrow involvement has decreased. Skin findings that were present may resolve, but this is not always the case.

What Should You Watch For and When to See a Doctor?

You do not need to check your skin for signs of myeloma. The disease is rare — about 7 people per 100,000 get it each year, according to the American Cancer Society. The symptoms that matter are bone pain, especially in the back or ribs, unexplained fractures, fatigue, frequent infections, and kidney problems.

If you notice new bruises or red spots that do not go away, mention it to your doctor. Same for any firm, growing lump under the skin. These are not emergencies, but they warrant a conversation.

Do not rely on photos online to diagnose yourself. The appearance of skin findings varies widely between people. What looks like a petechiae rash in one person may look completely different in another. Only a doctor can interpret these findings correctly.

If you have been diagnosed with multiple myeloma, tell your oncologist about any new skin changes. They can determine whether it is related to the cancer, a side effect of treatment, or something unrelated. Skin involvement may change your treatment plan.